P J Schlegel, W E Samlowski, J H Ward. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh： See more » Adjuvants, Immunologic/adverse effectsAdjuvants, Immunologic/therapeutic useAgedAnemia, Hemolytic, Autoimmune/etiologyAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useCarcinoma, Renal Cell/complicationsCarcinoma, Renal Cell/drug therapyHumansInjections, IntravenousInterleukin-2/adverse effectsInterleukin-2/analogs & derivativesInterleukin-2/therapeutic useKidney Neoplasms/complicationsKidney Neoplasms/drug therapyLeukemia, Lymphocytic, Chronic, B-Cell/complicationsLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyMaleNeoplasms, Multiple Primary/complicationsNeoplasms, Multiple Primary/drug therapyRecombinant Proteins/adverse effectsRecombinant Proteins/therapeutic use
Substances： See more » Adjuvants, ImmunologicAntineoplastic AgentsInterleukin-2Recombinant Proteinsaldesleukin
Year: 2000 PMID： 10916762 DOI： 10.1097/00002371-200007000-00016
Source DB: PubMed Journal: J Immunother ISSN： 1524-9557 Impact factor: 4.456